Thu, 30 July 2015
Big oil continues to report their latest results, and the Motley Fool’s Tyler Crowe and Taylor Muckerman dive in. |
Thu, 30 July 2015
Motley Fool analysts dig into Teva Pharmaceuticals recent M&A and debate the single most important number reported in Gilead Sciences second quarter earnings results. |